Loading
Total declarations
Companies
▲ Purchases (76 ops.)
▼ Sales (12 ops.)
Latest filing published 20 Mar 2025 for Black Diamond Therapeutics, Inc., €1.9M.
Filing timeline
BuySaleGrowth N. Biotech V
Insider track record
Disclosed buys
76
Disclosed sells
12
T+90 hit rate
100%
T+90 mean return
+40.6%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Growth N. Biotech V: trading record in brief
Filings by Growth N. Biotech V span 3 companies, the busiest being Radius Health, Inc., Black Diamond Therapeutics, Inc. and ESSA Pharma Inc. The record holds 94 filings, for trades running from 6 June 2014 to 19 March 2025.
Market trades split into 76 purchases (€136.2M) and 12 sales (€22.1M). Taken together, the purchases exceed the sales by €114.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants. Since January 2025: no purchases and 7 sales on the market.
Half of the purchases are above €1.3M and half below. Of 66 purchases, 8 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 20 March 2025, reports an open-market sale of €765k in Black Diamond Therapeutics, Inc. The last insider purchase was made public on 19 October 2023, 1,101 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Growth N. Biotech V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
1,000,000 shares@ US$2.069110.4% of flowCommon StockSEC:0001104659-25-026305:0
2,000,000 shares@ US$1.53212.4% of flowCommon SharesSEC:0000950170-24-121206:0
2,000,000 shares@ US$1.525912.3% of flowCommon SharesSEC:0000950170-24-121206:1
1,879,583 shares@ US$1.51311.5% of flowCommon SharesSEC:0000950170-24-121206:3
2,000,000 shares@ US$1.529412.3% of flowCommon SharesSEC:0000950170-24-121206:2
400,000 shares@ US$2.33524.8% of flowCommon StockSEC:0000950170-23-054142:0
Canonical exit: 15 Jan 2024 (T+90)
1,000,000 shares@ US$5.0025.2% of flowCommon StockSEC:0000950170-23-031386:0
Canonical exit: 28 Sept 2023 (T+90)
1,740,000 shares@ US$5.491447.8% of flowCommon StockSEC:0000899243-23-016705:0
Canonical exit: 25 Sept 2023 (T+90)
99,801 shares@ US$2.25361.2% of flowCommon StockSEC:0000899243-22-034751:0
Canonical exit: 29 Jan 2023 (T+90)
191,678 shares@ US$1.87412.0% of flowCommon StockSEC:0000899243-22-034543:0
Canonical exit: 25 Jan 2023 (T+90)
1,500,000 shares@ US$3.97926.0% of flowCommon SharesSEC:0000899243-22-034401:0
Canonical exit: 24 Jan 2023 (T+90)
87,850 shares@ US$1.51110.7% of flowCommon StockSEC:0000899243-22-034121:0
Canonical exit: 19 Jan 2023 (T+90)
77,689 shares@ US$1.32290.6% of flowCommon StockSEC:0000899243-22-033945:0
Canonical exit: 17 Jan 2023 (T+90)
300,000 shares@ US$3.15584.1% of flowCommon SharesSEC:0000899243-22-026410:0
Canonical exit: 16 Oct 2022 (T+90)
347,204 shares@ US$2.79214.2% of flowCommon SharesSEC:0000899243-22-026225:0
Canonical exit: 12 Oct 2022 (T+90)
150,000 shares@ US$2.66322.1% of flowCommon StockSEC:0000899243-22-016006:0
Canonical exit: 26 Jul 2022 (T+90)
25,100 shares@ US$5.85360.7% of flowCommon SharesSEC:0000899243-22-015831:0
150,000 shares@ US$3.29292.5% of flowCommon StockSEC:0000899243-22-015145:0
Canonical exit: 17 Jul 2022 (T+90)
150,000 shares@ US$3.4242.6% of flowCommon StockSEC:0000899243-22-014768:0
Canonical exit: 11 Jul 2022 (T+90)
250,000 shares@ US$8.87529.1% of flowCommon SharesSEC:0000899243-21-033765:0
Canonical exit: 16 Nov 2021 (T+90)
38,259 sharesCommon StockSEC:0000899243-16-012141:0
Canonical exit: 21 Apr 2016 (T+90)
50,000 sharesCommon StockSEC:0000899243-16-011711:0
Canonical exit: 12 Apr 2016 (T+90)
22 of 22 declarations
